Cargando…
miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1
Although the molecular biology of GC has been well characterized, early diagnostic biomarkers and effective therapeutic options in gastric cancer are still under investigation. Here, we found that miR‐148b expression decreased in human gastric cancer tissues compared with matched adjacent nontumor t...
Autores principales: | Ding, Xiangfu, Liu, Jingjing, Liu, Tianzhou, Ma, Zhiming, Wen, Dacheng, Zhu, Jiaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463086/ https://www.ncbi.nlm.nih.gov/pubmed/28440026 http://dx.doi.org/10.1002/cam4.1008 |
Ejemplares similares
-
MiR‐5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer
por: Miao, Yongchang, et al.
Publicado: (2020) -
HOTAIRM1 competed endogenously with miR‐148a to regulate DLGAP1 in head and neck tumor cells
por: Zheng, Mei, et al.
Publicado: (2018) -
MiR‐375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion
por: Wu, Yadong, et al.
Publicado: (2017) -
MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR
por: Jia, Tingting, et al.
Publicado: (2020) -
Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia
por: Fang, Xinhui, et al.
Publicado: (2020)